Localized Innovation Reshaping Digital Healthcare: Insights from Black Book's 2025 EHR Market Survey Covering Two-Thirds of Global Vendors

Global logistics expansion and alternative solutions help medical OEMs maintain momentum.

Beiersdorf Sponsors Top Dermatology Residents to Attend the 2025 Maui Derm-Hawaii Conference

In-Home Consumer Harvests Increase Exponentially After Research Discovery at Hypha Laboratories

Seasoned leader will support Vytalize Health's physician partners in delivering holistic, patient-centered care that enhances outcomes and strengthens patient-doctor relationships

- Engaged BSI Group to start the process of obtaining regulatory clearance of the MODD1, next-generation insulin pump for the European market

- Targeting Q1 2026 for expected clearance of the MODD1 in the E.U.

Funding from the NIH's National Institute on Drug Abuse (NIDA) will Support Development of ENA-001, an Agnostic Respiratory Stimulant, for Community Drug Overdose and as a Medical Countermeasure

ASCCP and NCI Publish Guidance in the Journal of Lower Genital Tract Disease; BD Onclarity HPV Assay Identifies Risk by HPV Type for Tailored Management

Englewood Health sought an innovative cloud Enterprise Imaging Platform that could streamline clinical and administrative operations, and relieve current and future system infrastructure needs. They found that solution along with an alliance with the ideal partner, AGFA HealthCare.

Gastrointestinal disorders are the most frequently reported adverse effects during clinical trials of GLP-1 agonists; GI adverse events usually develop in 40-70% of treated patients, and have been reported in up to 85%

Crofelemer, approved by the FDA under the brand name Mytesi^® for HIV-related diarrhea, has demonstrated a significant benefit in improving gastrointestinal symptoms, including diarrhea, abdominal pain and discomfort, incontinence, bloating and constipation, when studied in populations with HIV-related diarrhea, cancer therapy-related diarrhea, and IBS

- This is Dermata's first issued U.S. patent for XYNGARI™, which uses its Spongilla technology to topically treat acne -

- Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI™ clinical trial in March 2025 -

- Over 30 million acne patients seek treatment in the U.S. each year, with topical products being first-line therapy -

New document compares vaccine risks to 10 disease risks

A range of clinical topics will be covered throughout the year at the in-person events held in Southern California.

Empowering healthcare IT departments to experience Grow, Work, and Life - In Balance, with AGFA HealthCare's unified, purpose-built, modern Enterprise Imaging Platform.

2025 list recognizes leading health systems, hospitals and physician practices

The new facility, located on Oakside Lane, will offer an expanded space with improved accessibility for patients.

MDR Certification Strengthens Resyca’s Leadership in Soft Mist Drug-Device Combination Products

Oxidative stress drives aging and is a key factor in diseases like Alzheimer's, Age-related Macular Degeneration (AMD), cardiovascular diseases, cancer, and diabetes. It also plays a critical role in the progression of viral infections, such as avian influenza (bird flu), by exacerbating inflammation and cellular damage. Directly addressing oxidative stress and its consequences is essential to treating the underlying causes of these conditions and mitigating the severity of viral outbreaks.

New document compares vaccine risks to 10 disease risks

Revolutionary Oral Interferon Technology Combines Unmatched Advantages and Global Potential in the $16 Billion Coronavirus Market

Legislative Changes Usher Acceptance, Broaden Market Opportunity for Early Adopters

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry, and best in class biology to cut drug development timelines and costs, transforming cancer and rare disease treatments.

Company raises $24.6 million seed round, co-led by General Catalyst and Reid Hoffman with participation from Greylock, and establishes partnership with Microsoft.

HAHN Automation Group is eagerly preparing for the upcoming MD&M West trade show, where we will showcase our state-of-the-art assembly and test solutions designed specifically for the medical device industry.

Redefining Trust in Deworming Solutions with Unmatched Purity and Rigorous Quality Standards

WireDaily releases its new and updated analysis of LeanBiome reviews and complaints to help consumers make better informed choices in this regard.

WireDaily releases its new and updated analysis of Nagano Tonic reviews and complaints to help consumers make better-informed decisions.

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats

WireDaily releases its new and updated analysis of Gluco6 reviews and complaints to help consumers get informed opinions and well-prepared information.